Enable JavaScript to visit this website.

Health of Tomorrow

Coronavirus and Immunity: Key Questions as Society Begins to Reopen

Coronavirus and Immunity: Key Questions as Society Begins to Reopen

Coronavirus and Immunity: Key Questions as...

As states and countries slowly begin to ease social distancing restrictions for COVID-19, key questions remain unanswered around immunity to the novel coronavirus: If someone was infected with SARS-CoV-2 and recovered, how long do antibodies remain in their body, and are they protected against...

Empowering People with ‘Super Genes’ to Help Unlock New Treatment Pathways

Empowering People with ‘Super Genes’ to Help Unlock New Treatment Pathways

Empowering People with ‘Super Genes’ to Help...

Living among us today are people who carry “super genes” with variants that make them resilient to certain diseases. Some successful medicines mimic these genes, such as a new bone-builder that is based on families with genetically strong bones. If scientists could find patients with genetic...

COVID-19 as a Catalyst for Modernizing Clinical Trials

COVID-19 as a Catalyst for Modernizing Clinical Trials

COVID-19 as a Catalyst for Modernizing Clinical...

As the coronavirus outbreak swept the globe this spring, it led to major disruptions in clinical trials. With stay-at-home orders in place and the health care system stretched to capacity, many clinical studies for drugs to treat a variety of conditions came to a halt or had to cease enrolling...

New Hope for a Once Neglected Disease: Advances in Sickle Cell Treatments

New Hope for a Once Neglected Disease: Advances in Sickle Cell Treatments

New Hope for a Once Neglected Disease: Advances...

When Kelly Knee was in graduate school in the early 2000s, she found it nearly impossible to secure grant funding for research on sickle cell disease, a rare blood disorder that historically has been a neglected area of medical research. But hearing stories from patients, who suffer severe pain...

New Pathways to Cachexia Treatment: Focusing on Patient Quality of Life

New Pathways to Cachexia Treatment: Focusing on Patient Quality of Life

New Pathways to Cachexia Treatment: Focusing on...

Patients living with certain underlying chronic illnesses, such as cancer, chronic obstructive pulmonary disease (COPD), congestive heart failure, and other diseases often experience a syndrome called cachexia, which can cause anorexia, unintentional weight loss, muscle wasting, loss of appetite,...

Sweet Science: How Insights into Fructose Metabolism Are Helping to Fight Liver Disease

Sweet Science: How Insights into Fructose Metabolism Are Helping to Fight Liver Disease

Sweet Science: How Insights into Fructose...

If you check the labels on your favorite jarred marinara sauce, low-calorie salad dressing, or loaf of bread, you may be surprised to find that they contain added simple sugars — one of the most popular forms of which is high-fructose corn syrup (HFCS), a sweetener used in many processed...

Joining Forces to Share Data to Fight COVID-19

Joining Forces to Share Data to Fight COVID-19

Joining Forces to Share Data to Fight COVID-19

In the battle against COVID-19, big data has been critical to nearly every aspect of the global response: from tracking the spread of the virus and understanding the course of the disease to coordinating supply of personal protective equipment (PPE) and ventilators in hospitals. ...

 What Makes an RNA Vaccine Different From a Conventional Vaccine?

What Makes an RNA Vaccine Different From a Conventional Vaccine?

What Makes an RNA Vaccine Different From a...

Researchers and scientists around the world are working to develop a potential COVID-19 vaccine. Given the urgency of the pandemic, different groups are using different methods. ...

AI in Drug Safety: Building the Elusive ‘Loch Ness Monster’ of Reporting Tools

AI in Drug Safety: Building the Elusive ‘Loch Ness Monster’ of Reporting Tools

AI in Drug Safety: Building the Elusive ‘Loch...

Whenever a patient takes a drug and has an unexpected side effect — from minor problems like a runny nose to more serious ones that require hospitalization — pharma companies are legally required to report this information, known as an adverse event (AE), to regulatory agencies. ...

Get the Latest Updates